Sagility Ltd
Incorporated in July 2021, Sagility India Limited (formerly Berkmeer India Pvt. Ltd) provides healthcare-focused technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments.[1]
- Market Cap ₹ 24,427 Cr.
- Current Price ₹ 52.2
- High / Low ₹ 57.9 / 37.6
- Stock P/E 30.6
- Book Value ₹ 19.0
- Dividend Yield 0.10 %
- ROCE 9.58 %
- ROE 7.38 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Stock is trading at 2.75 times its book value
- Promoter holding has decreased over last quarter: -16.4%
- Company has a low return on equity of 4.89% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 8m | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 923 | 4,218 | 4,754 | 5,570 | 6,219 | |
| 730 | 3,179 | 3,665 | 4,263 | 4,692 | |
| Operating Profit | 193 | 1,039 | 1,088 | 1,307 | 1,526 |
| OPM % | 21% | 25% | 23% | 23% | 25% |
| 18 | 5 | 28 | 47 | 122 | |
| Interest | 65 | 215 | 185 | 127 | 112 |
| Depreciation | 147 | 644 | 689 | 467 | 470 |
| Profit before tax | -2 | 186 | 242 | 760 | 1,066 |
| Tax % | 152% | 23% | 6% | 29% | |
| -5 | 144 | 228 | 539 | 799 | |
| EPS in Rs | -0.02 | 0.75 | 0.53 | 1.15 | 1.71 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 82% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 291% |
| TTM: | 175% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 21% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 5% |
| Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 1,919 | 1,919 | 4,285 | 4,679 | 4,679 |
| Reserves | 2,108 | 4,288 | 2,158 | 3,657 | 4,215 |
| 4,788 | 2,896 | 2,532 | 1,402 | 1,232 | |
| 1,271 | 1,427 | 1,554 | 1,179 | 1,401 | |
| Total Liabilities | 10,085 | 10,529 | 10,529 | 10,917 | 11,527 |
| 8,621 | 8,607 | 8,667 | 8,997 | 9,076 | |
| CWIP | 5 | 0 | 6 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 247 |
| 1,459 | 1,922 | 1,856 | 1,920 | 2,204 | |
| Total Assets | 10,085 | 10,529 | 10,529 | 10,917 | 11,527 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -32 | 857 | 973 | 1,214 | |
| -7,711 | -101 | -463 | -958 | |
| 8,116 | -545 | -751 | -256 | |
| Net Cash Flow | 374 | 211 | -241 | -0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 366 | 92 | 91 | 83 |
| Inventory Days | ||||
| Days Payable | ||||
| Cash Conversion Cycle | 366 | 92 | 91 | 83 |
| Working Capital Days | 58 | 13 | -6 | 25 |
| ROCE % | 5% | 5% | 10% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Credit Rating
23 Jan - ICRA upgraded then withdrew Sagility's long- and short-term bank-facility ratings; press release dated January 22, 2026.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
19 Jan - Earnings webinar for Q3 & 9M FY26 on Jan 28, 2026 at 7:30 PM IST.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Jan - RTA confirms no demat/remat requests during quarter ended December 31, 2025.
-
Board Meeting Intimation for Board Meeting Intimation For Considering, Approving And Taking On Record The Unaudited Financial Results For The Quarter Ended On December 31, 2025, Along With Limited Review Report Thereon
8 Jan - Board meeting Jan 28, 2026 to approve unaudited Q3 (Dec 31, 2025) results; trading window closed Jan 1–30, 2026.
-
Announcement under Regulation 30 (LODR)-Credit Rating
5 Jan - CRISIL assigned Crisil A/Stable (long-term) and Crisil A1 (short-term) to Rs.300 crore bank facilities.
Concalls
-
Oct 2025TranscriptPPT
-
Oct 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
Market Share[1] Headquartered in Bangalore, the company serves only US customers. It holds 1.23% of the U.S. healthcare outsourcing market as of 2023.